This inventor holds 1 USPTO granted patent. Top assignee: Zentiva, A.s.. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Kamal Jarrah: Innovator in Pharmaceutical Manufacturing
Introduction
Kamal Jarrah is a notable inventor based in Praha, Czech Republic. He has made significant contributions to the field of pharmaceutical manufacturing, particularly in the synthesis of important compounds. His work has led to advancements that benefit the medical community and patients alike.
Latest Patents
Kamal Jarrah holds a patent for a method of manufacturing glimepiride, a medication used to treat type 2 diabetes. The patent details a process wherein trans-4-methylcyclohexylamine pivalate is reacted with a specific sulfonyl carbamate to produce glimepiride. This innovative method enhances the efficiency and effectiveness of producing this essential drug.
Career Highlights
Kamal Jarrah is currently employed at Zentiva, a prominent pharmaceutical company known for its commitment to quality and innovation. His role at Zentiva allows him to apply his expertise in drug manufacturing and contribute to the development of new therapeutic solutions.
Collaborations
Kamal collaborates with Stanislav Radl, a fellow professional in the pharmaceutical industry. Their partnership exemplifies the importance of teamwork in driving innovation and achieving successful outcomes in research and development.
Conclusion
Kamal Jarrah's contributions to pharmaceutical manufacturing, particularly through his patent for glimepiride, highlight his role as an innovator in the field. His work at Zentiva and collaboration with colleagues further emphasize the impact of teamwork in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile